Italian Group Shows Promise of Life Tech Digital PCR for 'Absolute' Assessment of HER2 Amplification | GenomeWeb

Researchers from Italy's University of Genoa and other institutions have produced unpublished early data suggesting that digital PCR assays run on Life Technologies' recently launched QuantStudio 3D platform may be useful in measuring HER2 copy number in borderline-amplified breast cancer research samples.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.